Opinions of Healthcare Providers About a European Neuromodulation Register
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this online survey is to gain further insights in the needs and burden for a European registry for neuromodulation, according to healthcare providers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2023
CompletedStudy Start
First participant enrolled
August 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2023
CompletedFirst Posted
Study publicly available on registry
September 11, 2023
CompletedSeptember 11, 2023
September 1, 2023
2 days
August 26, 2023
September 2, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Healthcare providers their current degree of participation in a registry for neuromodulation.
Degree of participation in a registry for neuromodulation (question).
Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Healthcare providers their need for a European registry.
Underlying reasons on why a European registry is needed, or not needed (question).
Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Items that should be included in a registry for neuromodulation, according to healthcare providers.
Items that should be collection within a registry, evaluated with a multiple choice question.
Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Access regulations to European registry for neuromodulation, according to healthcare providers.
Access regulations, evaluated with a multiple choice question.
Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Study Arms (1)
Healthcare professionals involved in neuromodulation
Interventions
Professionals are asked to complete questions regarding 1) the degree of current participation in a registry, 2) the need for a European registry, 3) the items that should be collected and 4) access to the European registry.
Eligibility Criteria
In this study male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses) will be eligible to complete the survey. The survey will be spread at the 3ʳᵈ Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg from 31/8/2023 to 2/9/2023.
You may qualify if:
- Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).
You may not qualify if:
- Not involved in management of chronic pain through neuromodulation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Moens Maartenlead
- Vrije Universiteit Brusselcollaborator
Study Sites (1)
Congres Center
Hamburg, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 26, 2023
First Posted
September 11, 2023
Study Start
August 31, 2023
Primary Completion
September 2, 2023
Study Completion
September 2, 2023
Last Updated
September 11, 2023
Record last verified: 2023-09